Canada’s Top Growth Stocks Under $2

Well Health and Hamilton Thorne are two high growth companies with a low stock price. Will they outperform broader markets in 2020?

| More on:
edit Colleagues chat over ketchup chips

Image credit: Photo by CIRA/.CA.

Investors are attracted to stocks with low share prices. You can purchase a significantly higher number of shares if the stock price is low. Here we look at two such Canadian growth stocks that are trading below $2 and might be an attractive buy at the current price.

Well Health Technologies

Shares of Well Health Technologies (TSX:WELL) are trading at $1.9. Well Health is a Canada-based company that operates primary healthcare facilities and an EMR (emergency medical records) business. It provides SaaS (software-as-a-service) EMR services to doctors across Canada.

According to analyst estimates, Well Health is expected to increase sales by a staggering 303% year over year to $32 million in 2019, up from $7.95 million in 2020. Sales are estimated to touch $44.1 million in 2020 and $58.4 million in 2021.

This growth will give a boost to the company bottom-line as well. Analysts expect company EBITDA to improve from -$1.81 million in 2019 to $1.05 million in 2020 and $3.9 million in 2021.

The stock has a market cap to forward 2020 sales ratio of five — a bargain considering the company’s growth metrics and rising profit margins.

Well Health went public on April 1 2016 and closed trading at $0.11 that day. Its shares have returned over 1,600% since then. If you had invested $1,000 in this penny stock IPO, it would have been worth about $16,000 today.

Well Health is now the third-largest medical records provider in Canada. The company is focusing on consolidating and modernizing clinical and digital assets in Canada’s healthcare segment. Analysts tracking Well Health have a 12-month average target price of $2.4, indicating an upside potential of 27%.

Hamilton Thorne

Shares of  Hamilton Thorne (TSXV:HTL) are trading at $1.32 at writing. The company is engaged in the development, manufacture and sales of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. Hamilton Thorne is one of the leading companies in the ART (Assisted Reproductive Technology) space.

The company is valued at $165 million in terms of market cap, and shares have gained close to 29% in the last year. In the last five years, shares have returned 277% easily outpacing the broader market. This growth has been supported by a stellar increase in the company’s financial metrics.

In the December quarter, it reported sales of $10.8 million, up 34% year over year. EBITDA grew 27% year over year to $2.2 million. In 2019, sales rose 21% to $35.3 million, while adjusted EBITDA grew 14.6% to $7.1 million.

The company is banking on huge wins in the United States and the United Kingdom to boost top-line growth in 2020. It is also eying growth via acquisitions to gain traction and drive sales higher.

Analysts expect company sales to reach $44.1 million in 2020 and $45.6 million in 2021. Comparatively, EBITDA might rise to $8.66 million in 2020 and $9.5 million in 2021.

In the last five years, the company’s revenue has risen at an annual rate of 31%, while EBITDA has risen by 71% annually in this period.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends HAMILTON THORNE LTD. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Investing

Doctor talking to a patient in the corridor of a hospital.

TFSA: Healthcare Dividend Stocks Are Perfect for Passive Income

Top healthcare dividend stocks like Extendicare Inc. (TSX:EXE) and others can provide huge passive income in your TFSA.

Read more »

TFSA and coins
Tech Stocks

TFSA: Invest in These 2 Stocks for a Legit Chance at $1 Million

Are you interested in building a $1 million portfolio? Invest $20,000 in these two stocks!

Read more »

edit Person using calculator next to charts and graphs

The Top TSX Stock on My Watch List Right Now

Here's why Alimentation Couche-Tard (TSX:ATD) remains a top TSX stock that long-term investors seeking growth and yield will want to…

Read more »

Hourglass projecting a dollar sign as shadow

3 Stocks to Add to Your TFSA ASAP

Given their stable cash flows and solid underlying businesses, these three stocks are excellent additions to your TFSA in this…

Read more »

edit Person using calculator next to charts and graphs
Dividend Stocks

Better Buy: Fortis Stock vs Enbridge

Fortis stock and Enbridge are top dividend stocks on the TSX today. Which stock is better buy for safe dividend…

Read more »

Canadian Dollars
Dividend Stocks

How to Make $1,500 in Passive Income 4 Times a Year

Blue-chip TSX stocks such as Enbridge can enable investors to create game-changing wealth over the long term.

Read more »

Woman has an idea

5 Stocks You Can Confidently Invest $500 in Right Now

Consider putting your surplus cash in these stocks for stellar capital gains.

Read more »

Dividend Stocks

TFSA: How to Easily Turn $10,000 Into $500/Year of Passive Income

You don't need to be a stock market expert to turn $10,000 into a $500 of tax-free passive income. Here's…

Read more »